Product Images Emtricitabine And Tenofovir Disoproxil Fumarate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Emtricitabine And Tenofovir Disoproxil Fumarate NDC 59651-167 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg/150 mg (30 Tablets Bottle) - emtriteno fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg/150 mg (30 Tablets Bottle) - emtriteno fig1

This is prescription drug information for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, with each tablet containing 100 mg of Emtricitabine and 150 mg of Tenofovir Disoproxil Fumarate. The medication guide is to be provided separately for each patient by the pharmacist. The recommended dosage is to be determined by a healthcare provider. Store the tablets at controlled room temperature and keep them away from tampering.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 133 mg/200 mg (30 Tablets Bottle) - emtriteno fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 133 mg/200 mg (30 Tablets Bottle) - emtriteno fig2

This is a medication containing Emtricitabine and Tenofovir Disoproxil Fumarate Tablets. It is used under prescription, and comes in a pack of 30 film-coated pills. The usual dosage is specified in the package inset. The pills should be stored between 68°F to 77°F and dispensed in the original container only. Aurobindo Pharma USA Inc. distributed the medicine, which was manufactured in India. Additional details about its use are available in the Medication Guide provided separately to each patient. The text also indicates that there is a printing zone and a coding area on the container, with instructions not to print on the dotted lines in the zone.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 167 mg/250 mg (30 Tablets Bottle) - emtriteno fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 167 mg/250 mg (30 Tablets Bottle) - emtriteno fig3

This is a description of a prescription medication with the NDC code 59651-167-30. The medication is a tablet containing emtricitabine and tenofovir disoproxil fumarate, with each tablet containing 167mg of emtricitabine and 250mg of tenofovir disoproxil fumarate. The medication guide should be provided separately to each patient by the pharmacist. Dosage and administration instructions are included in the package insert. The medication should be stored at a temperature between 20° C and 25° C and in the original container. This medication is made in India and distributed by Aurobindo Pharma USA, Inc.*

structure1 - emtriteno str1

structure1 - emtriteno str1

structure2 - emtriteno str2

structure2 - emtriteno str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.